Aiosyn

Nijmegen, Netherlands Founded: 2021 • Age: 5 yrs
AI-based tools are developed for clinical disease diagnosis by providers.
Annual revenue - Latest available
Total funding $4.9M 3 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Aiosyn

Aiosyn is a company based in Nijmegen (Netherlands) founded in 2021 by Jeroen Van der Laak, Patrick De Boer, and Wouter Bulten. Aiosyn has raised $4.94 million across 3 funding rounds from investors including TNO, Oost NL and Health Innovations. Aiosyn operates in a competitive market with competitors including PaxeraHealth, Bio-AI Health, Visla Labs, Carenostics and lifespin, among others.

  • Headquarter Nijmegen, Netherlands
  • Founders Jeroen Van der Laak, Patrick De Boer, Wouter Bulten
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $4.94 M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.82 M (USD), Series A

    Sep 09, 2025

  • Investors
    TNO

    & 3 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Aiosyn

Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Patrick de Boer
Co-founder & CEO Aiosyn
People
David Tellez
Chief Technology Officer
People
Jeroen van der Laak
Chief Scientific Officer
People
Wouter Bulten
Chief Operating & Product Officer (coo / Cpo)

Unlock access to complete

Funding Insights of Aiosyn

Aiosyn has successfully raised a total of $4.94M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.82 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Aiosyn

Aiosyn has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include TNO, Oost NL and Health Innovations.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Health Innovations is focused on investing in healthcare improvements.
Locked Locked Locked
Sector-agnostic VC firm investing in geographies such as the Netherlands
Locked Locked Locked
Opportunities are created for impact-driven ventures in emerging technologies.
Locked Locked Locked
Premium access

Investor details for Aiosyn

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aiosyn

Investments
Premium access

Investment portfolio details for Aiosyn

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aiosyn

Premium access

Detailed financials for Aiosyn

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aiosyn Comparisons

Aiosyn Primary company
Description
AI-based tools are developed for clinical disease diagnosis ...
Location
Nijmegen, Netherlands
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Aiosyn

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aiosyn

Aiosyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PaxeraHealth, Bio-AI Health, Visla Labs, Carenostics and lifespin, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-based medical image management solutions are offered for organizations.
Locked Locked Locked
AI-based disease diagnosis is provided for healthcare professionals.
Locked Locked Locked
Functions as an AI-based tool for disease diagnosis in healthcare.
Locked Locked Locked
AI-based tools are employed for disease diagnosis.
Locked Locked Locked
Cloud and AI-based diagnostics are provided for health providers.
Premium access

Detailed competitors of Aiosyn

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aiosyn

Premium access

Complete news archive for Aiosyn

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aiosyn

Aiosyn was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Aiosyn is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.

Patrick De Boer is the current CEO of Aiosyn. They have also founded this company.

Aiosyn is a funded company, having raised a total of $4.94M across 3 funding rounds to date.

Aiosyn was founded in 2021 in Nijmegen, Netherlands, within the health technology sector. Software has been created to support providers in clinical disease diagnosis, with specific features for breast and prostate cancer diagnostics, as well as computational pathology. Operations focus on AI-driven assistance for pathology workflows, targeting medical professionals in diagnostic processes across relevant geographies.

Aiosyn's top competitors include Bio-AI Health, lifespin and PaxeraHealth.

Aiosyn has 4 investors. Key investors include TNO, Oost NL, Health Innovations, and LUMO Labs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available